ArticleBMC endocrine disorders2026
Metabolic and hepatic differences among biochemically euthyroid individuals with distinct thyroid hormone sources: a comparative study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to evaluate the associations between thyroid hormone profiles and derived ratios (particularly the T3/T4 ratio), body composition parameters, and markers of hepatic steatosis and fibrosis in biochemically euthyroid individuals with distinct thyroid physiologies. Specifically, we sought to compare patients without endogenous thyroid hormone production following total thyroidectomy, patients with Hashimoto's thyroiditis, and healthy controls.
methodIn this retrospective, cross-sectional study, three groups with serum TSH levels within the reference range were included: (i) patients with hypothyroidism due to Hashimoto's thyroiditis (HT, n = 123), (ii) patients who had undergone total thyroidectomy (TT, n = 103) for benign conditions, and (iii) healthy control subjects (C, n = 83). Thyroid hormone levels and ratios (T3/T4, T3/TSH, T4/TSH), anthropometric measurements, body composition parameters, and non-invasive indices of hepatic steatosis and fibrosis (Fatty Liver Index (FLI) and Fibrosis-4 index (FIB-4)) were assessed in all participants.
resultsThe T3/T4 ratio differed significantly across groups (controls > HT > TT; p < 0.001). Both patient groups exhibited higher FLI (p = 0.019) and FIB-4 (p = 0.002) scores than controls. In correlation analyses, the T3/T4 ratio was positively associated with FIB-4 exclusively in the TT group (r = 0.263, p = 0.007). In hierarchical multiple regression restricted to TT patients, age independently predicted FIB-4 (β = 0.553, p < 0.001), whereas visceral fat rating was not significant (p = 0.476). After adjustment for age and visceral adiposity, the T3/T4 ratio remained an independent predictor of FIB-4 (β = 0.201, p = 0.016). Although TT patients showed less favorable body composition (higher fat mass and visceral adiposity; lower muscle and bone mineral percentages), these parameters did not independently predict FIB-4.
conclusionThese findings demonstrate that thyroid hormone balance is not homogeneous even under biochemically euthyroid conditions and that differences in functional thyroid capacity may translate into distinct metabolic and hepatic consequences. Thyroid hormone ratios may therefore provide complementary clinical information, supporting a more tissue-oriented approach to the evaluation of the thyroid-liver axis. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.